Longer steroids or N-acetylcysteine for severe alcoholic hepatitis
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether giving corticosteroids for a longer time, or adding a medicine called N-acetylcysteine, can help people with severe alcoholic hepatitis. It is for patients who have been drinking heavily and recently developed jaundice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been drinking heavily (more than 4–5 drinks a day) and recently developed jaundice (yellowing of skin or eyes).
- You have a liver biopsy that shows alcoholic hepatitis, and blood tests show severe liver inflammation.
- You do not have active infections like hepatitis B, hepatitis C, or HIV, or untreated bacterial infections.
- You have not been treated with corticosteroids or other immune-suppressing drugs in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding N-acetylcysteine to standard treatment helps people with severe alcoholic hepatitis. It may improve liver outcomes, especially for those with a high Maddrey score.
This early-phase study is testing a treatment approach for people with alcoholic hepatitis (liver inflammation caused by heavy alcohol use). It may help by improving liver function and outcomes in people who meet specific lab and health criteria.
This trial compares two treatments for alcoholic hepatitis: a medicine called mycophenolate mofetil versus the standard steroid treatment. The goal is to see which one works better and has fewer side effects for patients with this liver condition.
This trial tests a new medicine called MRG-001 for people with severe alcoholic hepatitis, a liver condition caused by heavy drinking. The study aims to see if the drug can help improve liver function and reduce symptoms.
This trial tests an experimental drug for people with severe alcoholic hepatitis that did not improve with steroids. Participants should have a moderate level of organ failure, but not require a breathing tube or kidney dialysis.
This trial looks at the gut bacteria (microbiome) in people with severe alcoholic hepatitis to understand how it affects the illness. It may help doctors find better ways to treat this condition.
Hear when a new Alcoholic Hepatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.